+ Site Statistics
+ Resolve Accession
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
Submit PDF Full TextSubmit PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of growth hormone release from the pituitaries of rats in vitro

, : Regulation of growth hormone release from the pituitaries of rats in vitro. Endocrinology 108(3): 1071-1080

In vitro studies were performed to investigate the regulation of GH [growth hormone] release from the pituitary of rats using the synthetic pentapeptides, Tyr-DTrp-Gly-Phe-Met-NH2 (DTrp2) or Tyr-Ala-DTrp-Phe-Met-NH2 (DTrp3), and the synthetic tetradecapeptide somatostatin (SRIF). DTrp2/3 act directly on the pituitary to specifically release GH and presumably mimic the action of the putative hypothalamic native GH-releasing hormone. The GH release induced by DTrp2/3 was dose related, occurred within 5 min, and was inhibited by small amounts (10-30 ng/ml incubation medium) of SRIF. Particular emphasis was given to the possibility that GH from the pituitary of immature rats and mature rats may be influenced differently at the pituitary level. This latter conclusion was supported by the finding that the GH released by DTrp2/3 from the pituitary of the mature rat compared to that released in the immature rat was greater in magnitude but more easily inhibited by SRIF. Other differences included: progressively decreasing GH release from the pituitary of the mature, but not the immature rat on repeated stimulation with DTrp2/3; the addition of glucose to the incubation medium caused a partial decrease of the GH response to DTrp2/3 from the pituitary of the mature and immature rat but only inhibited the unstimulated release of GH from the pituitary of the mature rat and temporary inhibition of the DTrp2/3 pituitary GH response of SRIF of the immature compared to the mature rat was more readily reversible. For comparison, some of the above studies were also performed using the GH-releasing agents prostaglandin [PG] E1 and theophylline (Theo) with and without DTrp2/3 and/or SRIF. Repeated stimulation with PGE1 and Theo, but not DTrp2/3 elicited a sustained release of GH from the pituitary of the mature rat; adding PGE1 or Theo with DTrp2/3 elicited a greater release of GH when the DTrp2/3 GH response alone was usually decreased during the last 2 h of a 6 h incubation. In contrast to the DTrp2/3 GH response, the PGE1 and Theo GH responses were immediately reversible after temporary inhibition with SRIF. DTrp2/3 may be unique pentapeptides for learning more about the function and behavior of the putative GH-releasing hormone receptor of the pituitary somatotrophs; the dual effects of SRIF plus DTrp2/3 rather than the effect of SRIF alone appear to produce an irreversible inhibition of the stimulated release of GH at the putative GH-releasing hormone-SRIF receptor(s) and studies on the regulation of GH release in vitro from the pituitaries of immature and mature rats may reveal certain unique differences which have important physiological implications in vivo.

(PDF 0-2 workdays service)

Order PDF Full Text


Click here to order any other PDF Full Text

Accession: 006288297

PDF Full Text: Submit

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Other references

Edghill, Emma, L.; Gloyn, Anna, L.; Goriely, Anne; Harries, Lorna, W.; Flanagan, Sarah, E.; Rankin, Julia; Hattersley, Andrew, T.; Ellard, Sian, 2007: Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings. Context: Activating mutations in the KCNJ11 gene, which encodes the Kir6.2 subunit of the pancreatic beta-cell K-ATP channel, result in permanent and transient neonatal diabetes. The majority of KCNJ11 mutations are spontaneous, but the parental...

Dudkin, V. M., 1983: Effectiveness of a crop rotation saturation with sugarbeet. Trials in 1969-80 showed that the proportion of sugarbeet in a 10-course crop rotation should not exceed 20%; with 30-40% sugarbeet yields are decreased due to deterioration of the soil moisture regime, increased weediness and disease infection.

Khuchua A.V.; Sharashidze G.L., 1975: Cytochemistry of various nerve cells of the canine motor cortex. Soobshcheniya Akademii Nauk Gruzinskoi SSR 77(1): 213-216

Quint H., 1974: Neurotic depression and the experience of aging psychoanalytic examination. Psychotherapy & Psychosomatics 24(1): 18-33

Bolcsak, Lois E.; Nerland, Donald E., 1983: Purification of mouse liver benzene dihydrodiol dehydrogenases. The Journal of Biological Chemistry 258: 52-5

Mohanty, B. K., 2003: Genetic variability, correlation and path coefficient studies in tomato. The genetic variability, coefficient of variation and heritability in 18 tomato cultivars were determined in a field experiment conducted in Orissa, India during the rabi season of 1997-98. High heritability with high genotypic coefficient of vari...

Bennejean, G.; Merat, P.; Perramon, A.; Guittet, M.; Picault, J. P., 1976: Blood types and mareks disease in the fowl resistance of a hetero zygous genotype. Comparisons between sexes, sire families and genotypes at 3 loci coding for erythrocyte membrane antigens were made in a study of resistance to Marek's disease. Resistance was determined by the absence of macroscopic lesions. The virus was in...

Frederiks, G., 1921: Note sur l'origine de l'appareil septal de Lyttoniinae. Annuaire de la Societe Paleontologique de Russie, 3: 108-110

Quaroni, E., 1977: Use of selected starters for the production of yoghurt. Latte 2 (1) 41-42

Petersen K G.; Khalaf A.; Zeisel H J.; Stryjek Kaminska D.; Kerp L., 1989: Ige antibodies to human growth hormone prior to and during treatment. Clinical manifestations of allergy to biosynthetic hGH were not reported in 245 patients treated for one year. A sensitive radioallergosorbent test showed, however, the presence of anti-hGH IgE antibodies in the sera of 13%. ALl patients with anti...